Genetic database gives hope for potential Parkinson’s treatment

News

Author: Saskia MairPublished: 4 June 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

DNA molecules genetic database

The Genome Aggregation Database (gnomAD) – the world’s largest public database of variations in DNA which can cause diseases – has given scientists hope for a potential Parkinson’s treatment.

UK and US researchers from Imperial College London, the Broad Institute of MIT and Harvard, 23andMe and the Michael J. Fox Foundation used gnomAD to study variants in the LRRK2 gene, which increases the risk of Parkinson’s. Previous studies have shown that blocking the protein formed by the gene can lead to organ damage in animals – but the scientists now suggest this approach should be safe for humans.

Research fellow Dr Nicky Whiffin said: “Large genetic databases are increasingly giving us a powerful insight into the likely impact of certain drugs. If we see that genetic variants that naturally reduce the amount of protein in our body do not result in severe diseases, we can be more confident that targeting that protein therapeutically will also be safe.”

For more information on the latest Parkinson’s research please visit the EPDA website.


Read more:

Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests

Can Covid-19 increase the risk of developing Parkinson’s?

Go Back

Share this story

Comments


Related articles


Chris Mamo

Interviews

Chris Mamo: 40,000 steps in 12 hours for Parkinson’s

The fundraiser who didn’t stop running for 12 hours

READ MORE
Professor

sponsored article

Advances

Deep Brain Stimulation for Parkinson’s disease just got smarter

Find out more about a new DBS innovation

READ MORE
Michael J Fox

Perspectives

Michael J Fox: “Now is our chance to honour Ali by finishing the fight he could not”

Remembering Muhammad Ali, two months after his death

READ MORE